Apollo Medical Holdings, Inc. (AMEH)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Apollo Medical Holdings, Inc. (AMEH) trades at $40.82 with AI Score 55/100 (Grade B). Apollo Medical Holdings, Inc. operates as a physician-centric, technology-powered healthcare company. Market cap: $1.83B, Sector: Healthcare.
Price live · AI analysis from May 9, 2026Analyst Coverage for AMEH: AMEH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AMEH against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
AMEH: 3/7 perspectives are bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →Apollo Medical Holdings, Inc. (AMEH) Healthcare & Pipeline Overview
Apollo Medical Holdings, Inc. delivers medical care services through its technology-driven, physician-centric model. The company's integrated, value-based healthcare platform empowers providers to coordinate patient care across various settings, primarily in California, serving both insured and non-insured individuals. They focus on optimizing healthcare delivery and patient outcomes.
What Is the Investment Thesis for AMEH?
Apollo Medical Holdings presents a compelling investment case centered on its technology-driven, value-based care model. The company's integrated platform and physician-centric approach are key value drivers. With a market capitalization of $1.83B and a P/E ratio of 60.8, the company's growth potential is tied to its ability to expand its network and improve care coordination. Key catalysts include expanding its services within California and potentially entering new markets. However, investors should be aware of risks such as maintaining profitability with a 0.9% profit margin and navigating the complex regulatory landscape of the healthcare industry.
Based on FMP financials and quantitative analysis
AMEH Key Highlights
- Market Cap of $1.83B reflects investor confidence in Apollo Medical's growth strategy.
- P/E Ratio of 60.8 indicates a premium valuation, suggesting high growth expectations.
- Gross Margin of 6.8% highlights the need for improved operational efficiency.
- Profit Margin of 0.9% signals potential challenges in maintaining profitability.
- Beta of 1.04 suggests that AMEH's stock price is slightly more volatile than the overall market.
Who Are AMEH's Competitors?
AMEH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| SLHGP Skylight Health Group Inc. | $12.00 | -5.88% | 61 | |
| SOLV Solventum Corporation | $78.20 | -0.09% | $13.54B | 55 |
| TALK Talkspace, Inc. | $5.20 | +0.12% | $871.07M | 55 |
| OSH Oak Street Health, Inc. | $39.00 | +0.08% | $9.52B | 55 |
| TLMD SOC Telemed, Inc. | $3.00 | +0.00% | 55 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AMEH's Key Strengths?
- Integrated technology platform for care coordination.
- Physician-centric approach.
- Value-based care model.
- Established presence in California.
What Are AMEH's Weaknesses?
- Low profit margin.
- Geographic concentration in California.
- Reliance on insurance reimbursements.
- High P/E ratio.
What Could Drive AMEH Stock Higher?
- Expansion of services within California, targeting new geographic areas and patient populations.
- Strategic acquisitions of complementary healthcare providers and technology companies.
- Development of new technology solutions to enhance care coordination and population health management capabilities.
- Partnerships with health plans to expand its network and increase patient referrals.
What Are the Key Risks for AMEH?
- Rich valuation — a P/E of 60.8 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Increasing competition in the healthcare industry could put pressure on pricing and market share.
- Changes in healthcare regulations could impact reimbursement rates and operational requirements.
- Economic downturn could lead to decreased patient volume and reduced insurance coverage.
- Cybersecurity risks could compromise patient data and disrupt operations.
- Maintaining profitability with a low profit margin of 0.9%.
What Are the Growth Opportunities for AMEH?
- Expansion within California: Apollo Medical Holdings can expand its services within California by targeting new geographic areas and patient populations. The California healthcare market is substantial, with significant opportunities to increase market share through strategic partnerships and acquisitions. By leveraging its existing infrastructure and technology platform, Apollo Medical can efficiently integrate new practices and expand its reach. This expansion could lead to increased revenue and improved profitability as the company achieves economies of scale.
- Strategic Acquisitions: Apollo Medical Holdings can pursue strategic acquisitions of complementary healthcare providers and technology companies to enhance its capabilities and expand its service offerings. By acquiring companies with specialized expertise or innovative technologies, Apollo Medical can strengthen its competitive position and attract new patients. These acquisitions can also provide access to new markets and patient populations, further driving revenue growth. The company should focus on targets that align with its value-based care model and technology-driven approach.
- Development of New Technology Solutions: Apollo Medical Holdings can invest in the development of new technology solutions to further enhance its care coordination and population health management capabilities. By leveraging data analytics and artificial intelligence, the company can identify high-risk patients, personalize care plans, and improve patient outcomes. These technology solutions can also streamline administrative processes, reduce costs, and improve the efficiency of its physician network. The company should prioritize solutions that address the evolving needs of its patients and providers.
- Partnerships with Health Plans: Apollo Medical Holdings can form strategic partnerships with health plans to expand its network and increase patient referrals. By partnering with health plans, the company can gain access to a broader patient base and secure preferred provider status. These partnerships can also provide opportunities to collaborate on value-based care initiatives and share risk. The company should focus on partnerships with health plans that are committed to improving patient outcomes and reducing healthcare costs.
- Expansion into New Markets: Apollo Medical Holdings can explore opportunities to expand its operations into new geographic markets beyond California. By replicating its successful business model in other states with favorable regulatory environments and growing healthcare needs, the company can significantly increase its revenue and market share. The company should carefully evaluate potential markets based on factors such as demographics, healthcare spending, and regulatory landscape. This expansion would require significant investment in infrastructure and personnel, but could yield substantial long-term returns.
What Opportunities Does AMEH Have?
- Expansion into new geographic markets.
- Strategic acquisitions of complementary businesses.
- Development of new technology solutions.
- Partnerships with health plans.
What Threats Does AMEH Face?
- Increasing competition in the healthcare industry.
- Changes in healthcare regulations.
- Economic downturn.
- Cybersecurity risks.
What Are AMEH's Competitive Advantages?
- Proprietary Technology Platform: Apollo Medical's integrated technology platform provides a competitive advantage by enabling efficient care coordination and population health management.
- Physician-Centric Model: The company's focus on empowering physicians and providing them with the tools and resources they need to deliver high-quality care creates a strong network effect.
- Value-Based Care Model: Apollo Medical's commitment to value-based care aligns with the evolving trends in the healthcare industry and positions it to capitalize on opportunities to improve patient outcomes and reduce costs.
- Established Presence in California: The company's long-standing presence in California provides a strong foundation for future growth and expansion.
What Does AMEH Do?
Founded in 1994 and headquartered in Alhambra, California, Apollo Medical Holdings, Inc. has evolved into a physician-centric, technology-powered healthcare company. The company operates an integrated, value-based healthcare model, leveraging its proprietary population health management and healthcare delivery platform. This platform empowers providers within its network to deliver coordinated care to patients across various settings. Apollo Medical Holdings offers care coordination services to a wide range of stakeholders, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network includes primary care physicians, specialist physicians, and hospitalists. Apollo Medical Holdings primarily serves patients covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans, as well as non-insured patients in California. Their focus on technology and coordinated care aims to improve patient outcomes and reduce healthcare costs.
What Products and Services Does AMEH Offer?
- Provides medical care services to patients in California.
- Operates an integrated, value-based healthcare model.
- Leverages a proprietary population health management and healthcare delivery platform.
- Offers care coordination services to patients, families, and healthcare providers.
- Manages a network of primary care physicians, specialist physicians, and hospitalists.
- Serves patients covered by private or public insurance, as well as non-insured patients.
How Does AMEH Make Money?
- Generates revenue through providing medical care services to patients.
- Receives payments from private and public insurance plans, including Medicare and Medicaid.
- Employs a value-based care model, focusing on improving patient outcomes and reducing costs.
- Utilizes its technology platform to manage patient care and coordinate services.
What Industry Does AMEH Operate In?
Apollo Medical Holdings operates within the rapidly evolving healthcare industry, which is undergoing significant transformation driven by technological advancements, regulatory changes, and a growing emphasis on value-based care. The industry is characterized by increasing consolidation, with larger healthcare systems and physician groups seeking to gain economies of scale and improve care coordination. Apollo Medical's focus on technology and integrated care positions it to capitalize on these trends. The competitive landscape includes established healthcare providers, technology companies, and emerging players focused on specific aspects of care delivery.
Who Are AMEH's Key Customers?
- Patients covered by private insurance plans.
- Patients covered by public insurance plans (Medicare and Medicaid).
- Non-insured patients in California.
- Primary care physicians, specialist physicians, and hospitalists within its network.
Apollo Medical Holdings, Inc. (AMEH) Valuation Context
Valued at $1.83B, AMEH is classified as a small-cap stock. Relative to its peer group, AMEH's quantitative score of 55/100 is roughly in line with the peer average of 61/100.
AMEH Revenue & Earnings Trend
In Q1 2026, AMEH generated $965.1M in top-line revenue, marking a sequential increase of 1.5%. The company recorded net income of $14.4M, with diluted EPS of $0.29. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare.
Company Profile
Apollo Medical Holdings, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Alhambra, US. The company is led by CEO Brandon Sim. AMEH has traded publicly since 2009.
ROE 4%Key Financial Metrics
Return on equity for Apollo Medical Holdings, Inc. stands at 3.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.3%, showing how much profit it generates from its asset base. AMEH trades at a trailing price-to-earnings ratio of 60.79, above the Healthcare sector average of ~23x. Its free cash flow yield is 8.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.35 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 1.6%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 5/9Financial Health
Apollo Medical Holdings, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.53 places it in the grey zone, a middle ground that warrants monitoring.
FY2026 estForward Outlook
Wall Street analysts project Apollo Medical Holdings, Inc. revenue of about $2.33B for fiscal 2026, with EPS near $2.47.
Net buyingInsider Activity
The most recent 11 insider filings for Apollo Medical Holdings, Inc. break down as 0 sales and 11 purchases. On net that is roughly 165K shares acquired (about $0) — insiders putting money in tends to read as conviction.
AMEH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Apollo Medical Holdings seems to be gaining traction within the social trading community. There's a growing sense that their integrated care model is resonating with patients and providers, potentially leading to increased market share.
- Recent insider activity suggests confidence in the company's long-term prospects. While not definitive, it's a signal that those closest to the business see value.
- The company's focus on value-based care is increasingly viewed as a positive, especially as healthcare systems look for ways to improve outcomes and reduce costs. This could position them well for future growth.
- There's a perception that Apollo Medical is successfully navigating the complexities of the healthcare industry, fostering a sense of stability and reliability among investors.
Bear Case
- Concerns linger about the sustainability of growth in a highly competitive healthcare market. It's unclear if they can maintain their current momentum.
- Community sentiment reveals skepticism regarding the company's ability to scale its operations effectively. Some worry about potential challenges in managing growth.
- Market perception suggests that regulatory changes in the healthcare sector could pose a risk to Apollo Medical's business model. Uncertainty surrounding policy changes is creating some unease.
- Despite positive buzz, some bearish voices question the long-term viability of their integrated care approach, suggesting potential limitations in reaching certain patient populations or geographic areas.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $965M | $14M | $0.29 |
| Q4 2025 | $951M | $5M | $0.09 |
| Q3 2025 | $1.61B | $1M | $0.01 |
Based on FMP financials and quantitative analysis
AMEH Latest News
No recent news available for AMEH.
AMEH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AMEH.
Price Targets
Wall Street price target analysis for AMEH.
AMEH MoonshotScore
What does this score mean?
The MoonshotScore rates AMEH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Brandon Sim
Unknown
Information about Brandon Sim's background is not available in the provided data. Further research would be needed to provide details on his career history, education, and previous roles.
Track Record: Information about Brandon Sim's track record is not available in the provided data. Further research would be needed to provide details on his key achievements, strategic decisions, and company milestones under his leadership.
What Investors Ask About Apollo Medical Holdings, Inc. (AMEH) — Healthcare
What does Apollo Medical Holdings, Inc. do?
Apollo Medical Holdings, Inc. operates as a physician-centric, technology-powered healthcare company focused on delivering medical care services. They utilize a proprietary population health management and healthcare delivery platform to operate an integrated, value-based healthcare model. This model empowers providers in their network to deliver coordinated care to patients across various settings, including primary care, specialist care, and acute care hospitals. The company primarily serves patients covered by private or public insurance in California.
What do analysts say about AMEH stock?
Analyst opinions on Apollo Medical Holdings, Inc. (AMEH) are not available within the provided data. To get a neutral summary of analyst consensus, key valuation metrics, and growth considerations, it is recommended to consult reputable financial analysis platforms such as Bloomberg or Yahoo Finance. These platforms provide up-to-date analyst ratings, price targets, and detailed financial analysis to aid in investment research. Remember to conduct your own due diligence before making any investment decisions.
What are the main risks for AMEH?
Apollo Medical Holdings, Inc. faces several risks inherent to the healthcare industry. Increasing competition could erode market share and pressure pricing. Changes in healthcare regulations, particularly regarding reimbursement rates and managed care policies, could significantly impact revenue. Economic downturns may reduce patient volume and insurance coverage rates. Cybersecurity threats pose a risk to sensitive patient data and operational continuity. The company's low profit margin of 0.9% also presents an ongoing risk to its financial stability.
What are the key factors to evaluate for AMEH?
Apollo Medical Holdings, Inc. (AMEH) holds an AI score of 55/100 (moderate). P/E: 60.8x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does AMEH data refresh on this page?
AMEH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven AMEH's recent stock price performance?
Apollo Medical Holdings, Inc. (AMEH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated technology platform for care coordination. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AMEH overvalued or undervalued right now?
Apollo Medical Holdings, Inc. (AMEH) trades at 60.8x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying AMEH?
Before investing in Apollo Medical Holdings, Inc. (AMEH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on available information and may not be fully comprehensive.
- CEO information is limited and requires further research.
- Analyst opinions were not available in the provided data.